Introduction:Affective disorders, including generalized anxiety disorder and post-traumatic stress disorder (PTSD), are reported in 18.1% of United States adults. Additionally, affective disorders develop and persist in up to 50% of traumatic brain injury (TBI) survivors, however, few common biological mechanisms between TBI and non-TBI patients have been elucidated 1, 2 .The incidence of TBI continues to rise, with at least 2.5 million Americans reporting a TBI each year, costing the American health care system 76.5 billion dollars 3 . Three-quarters of all TBIs are diffuse TBIs (dTBI) in which the signature pathology is multi-focal diffuse axonal injury with no overt pathology detected by CT or MRI 4-6 . dTBI subsequently induces secondary sequelae that occur seconds to months following the initial injury, leading to the development of affective, cognitive, and somatic symptoms 7, 8 . Despite clinical prevalence, the pathophysiology contributing to affective symptoms following dTBI is poorly understood, resulting in misdiagnosis and ineffective treatments 9-11 . Ultimately, affective symptoms impact a patient's ability to return to work, daily function, and social interactions, and thus severely impair the quality of life for both the patient and caregivers 12, 13 .Clinical and preclinical data demonstrate how the amygdala changes following dTBI. In veterans, early amygdala fMRI reactivity post-injury is predictive of the development of PTSD and could contribute to the bilateral reduction of amygdala size observed in patients diagnosed with both TBI and PTSD 14,15 . A study in collegiate football players report a positive correlation between amygdala shape and mood states 16 . TBI survivors with major depressive disorder had smaller lateral and dorsal prefrontal cortex, which mediates ventral-limbic and paralimbic pathways and influences amygdala circuitry 17 . Diffuse and focal experimental models of TBI also identify alterations in amygdala circuitry, including increased neuronal hyperexcitability and GABA production proteins in the absence of overt neuropathology 18,19 . In addition, pyramidal and stellate neurons in the basolateral amygdala (BLA) demonstrate increased complexity distal and proximal to the soma as early as 1 day post-injury (DPI) and lasted until at least 28DPI indicating BLA-central nucleus of the amygdala (CeA) circuit reorganization after dTBI 20 .Affective symptoms are controlled by limbic system circuitry with evidence that the direct stimulation of glutamatergic neurons originating in the BLA and projecting into the CeA 4 produces reversible anxiolytic symptoms 21 22 . BLA neurons are 90% glutamatergic, highlighting the role of glutamate neurotransmission in displays of affective behavior 23,24 . Glutamate neurotransmission is regulated by astrocytes and microglia processes surrounding the synapse 25 .Glutamate transporters, Glt-1 and GLAST (located on astrocytes), rapidly remove glutamate from the extracellular space, restricting glutamate to the synaptic cleft. 26,27 . When spillover...